Zacks Research Comments on Nutrien’s Q2 Earnings (TSE:NTR)

Nutrien Ltd. (TSE:NTR) – Equities researchers at Zacks Research raised their Q2 2026 EPS estimates for shares of Nutrien in a research note issued on Tuesday, May 19th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $3.36 for the quarter, up from their prior estimate of $3.27. The consensus estimate for Nutrien’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Nutrien’s Q3 2026 earnings at $1.24 EPS, Q4 2026 earnings at $1.24 EPS, FY2026 earnings at $6.30 EPS, Q1 2027 earnings at $0.83 EPS, Q2 2027 earnings at $1.69 EPS, Q3 2027 earnings at $1.15 EPS, Q4 2027 earnings at $1.32 EPS, FY2027 earnings at $4.98 EPS, Q1 2028 earnings at $1.04 EPS and FY2028 earnings at $5.56 EPS.

NTR has been the subject of several other research reports. Raymond James Financial upgraded Nutrien from a “hold” rating to a “moderate buy” rating in a research note on Tuesday, May 5th. Wells Fargo & Company upgraded Nutrien from a “hold” rating to a “strong-buy” rating in a report on Friday, March 13th. Jefferies Financial Group raised Nutrien from a “hold” rating to a “strong-buy” rating in a research report on Thursday, March 12th. Barclays upgraded shares of Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 27th. Finally, TD Securities boosted their target price on shares of Nutrien from C$72.00 to C$80.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Three research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of C$80.00.

Nutrien Trading Up 0.5%

Shares of TSE:NTR opened at C$96.82 on Friday. The company has a market cap of C$46.48 billion, a P/E ratio of 19.72, a P/E/G ratio of 1.15 and a beta of 1.12. The stock’s 50-day moving average is C$101.98 and its 200-day moving average is C$93.62. Nutrien has a 52-week low of C$74.77 and a 52-week high of C$116.95. The company has a debt-to-equity ratio of 55.44, a quick ratio of 0.65 and a current ratio of 1.24.

Nutrien (TSE:NTR) last released its earnings results on Wednesday, May 6th. The company reported C$0.71 earnings per share for the quarter. Nutrien had a net margin of 8.61% and a return on equity of 9.49%. The firm had revenue of C$8.41 billion during the quarter.

Insiders Place Their Bets

In related news, insider Christopher Reynolds acquired 2,400 shares of the firm’s stock in a transaction on Friday, May 8th. The shares were bought at an average cost of C$95.19 per share, with a total value of C$228,456.00. Following the completion of the acquisition, the insider owned 10,585 shares of the company’s stock, valued at C$1,007,586.15. This trade represents a 29.32% increase in their ownership of the stock. Also, Director Kenneth Alvin Seitz acquired 3,900 shares of the stock in a transaction dated Friday, May 8th. The stock was bought at an average price of C$94.52 per share, for a total transaction of C$368,628.00. Following the completion of the purchase, the director owned 47,513 shares in the company, valued at approximately C$4,490,928.76. This trade represents a 8.94% increase in their position. Insiders acquired a total of 7,300 shares of company stock worth $690,504 over the last quarter. Company insiders own 0.03% of the company’s stock.

Trending Headlines about Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research lifted Nutrien’s FY2026 EPS estimate to $6.30 from $6.07, signaling stronger expected full-year profitability.
• Positive Sentiment: The firm raised Q2 2026 EPS to $3.36 from $3.27 and Q3 2026 EPS to $1.24 from $1.03, suggesting improved near-term earnings momentum.
• Positive Sentiment: Zacks Research also increased its Q4 2026 estimate to $1.24 from $1.11 and Q4 2027 estimate to $1.32 from $1.12, reinforcing a more upbeat longer-range outlook.
• Positive Sentiment: Q1 2028 EPS was raised to $1.04 from $0.87, which may help support investor confidence in Nutrien’s earnings trajectory. Article Title
• Neutral Sentiment: Analysts still expect FY2027 EPS of $4.98 and FY2028 EPS of $5.56, both below the FY2026 forecast, indicating some moderation in growth later on.
• Negative Sentiment: Zacks trimmed FY2027 EPS to $4.98 from $5.91 and Q3 2027 EPS to $1.15 from $1.28, showing some caution around future profitability.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.